Engineering Innovation for Healthcare Solutions: How SPX FLOW Advances Patient Care
Beyond acute care, the company also supports long-term health through its solutions in the manufacturing process of fortified nutritional drinks which aid in addressing malnutrition, breastfeeding support and bone health in preterm infants and elderly individuals.
Where You'll Find SPX FLOW Solutions across the Healthcare Industry:
- Life-Saving Vaccines: World-renowned homogenizer, mixer and spray dryer brands play a crucial role in blending active pharmaceutical ingredients for medicines and vaccines, ensuring consistency and efficacy for consumers everywhere.
- Emergency Care Reliability:
Johnson Pump marine circulation pumps boost heating capacity in ambulances, ensuring life-saving medical equipment operates in critical moments. - Hospital-Grade HVAC Performance: APV heat exchangers support HVAC systems at one of the top cancer centers in the world, delivering industry-leading safety and efficiency.
- Advanced Medical Imaging: Anhydro spin dryers optimize contrast fluid for CT scans, helping doctors achieve clear, accurate diagnoses.
- Essential Hydration: Waukesha Cherry-Burrell centrifugal pumps accurately deliver saline solutions into IV bags for surgery and patient hydration.
SPX FLOW has a long history in playing a role in healthcare. Its mixing technology advancements supported World War II efforts by producing antibiotics, synthetic rubber and high-octane gasoline. More recently, a
About SPX FLOW, Inc.
Based in
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/engineering-innovation-for-healthcare-solutions-how-spx-flow-advances-patient-care-302383129.html
SOURCE SPX FLOW, INC.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sydney Romero Selected as the Winner of the Inaugural Rawlings Gold Glove Award® in the AUSL
- HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Can
- APIC delivers 55% EBITDA growth in the first half of 2026, reaching USD 44 million
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share